Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AT-278 by Arecor Therapeutics for Type 2 Diabetes: Likelihood of Approval
AT-278 is under clinical development by Arecor Therapeutics and currently in Phase I for Type 2 Diabetes. According to GlobalData,...